Accelerator Programs: RARE Grant Program (Research Accelerating RUNX1 Exploration)

Accelerator Programs: RARE Grant Program (Research Accelerating RUNX1 Exploration)

Status: ACTIVE
Funder: Alex’s Lemonade Stand Foundation for Childhood Cancer
Amount: Up to US $180,000
Last Updated: July 14, 2025

Summary

The RARE Grant Program, supported by Alex’s Lemonade Stand Foundation, focuses on pioneering research to prevent blood cancer in individuals with RUNX1 familial platelet disorder. This initiative aims to foster a new generation of scientists dedicated to inherited hematologic malignancies. The program offers a three-year grant of $180,000 to early career researchers, encouraging innovative approaches in developing therapies. By connecting researchers and stakeholders, the program enhances collaboration and knowledge dissemination within the RUNX1 community.

Overview

About RRP A research and advocacy venture committed to funding world-class, innovative, and cross-disciplinary cancer research to develop a cancer prevention therapy for RUNX1 familial platelet disorder (RUNX1-FPD) with predisposition to blood cancer. The program also aims to support, inform, educate, and connect patients, healthcare providers, researchers, and other stakeholders in the RUNX1 community.About Alex’s Lemonade Stand Foundation A non-profit changing the lives of children with cancer by funding impactful research, raising awareness, supporting families, and empowering everyone to help cure childhood cancer. RUNX1 Early Career Investigator Program – Basic and Translational ScienceThe RUNX1 Research Program and Alex’s Lemonade Stand Foundation are delighted to continue their partnership and funding opportunity for early career investigators: the RRP and ALSF RUNX1 Early Career Investigator Program.Key Objective To promote the establishment of a new generation of basic and translational scientists interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention. Program DescriptionThe RUNX1 Early Career Investigator grant is a three-year award designed to fund research investigating strategies that will lead to the development of therapies that will prevent the transition from pre-malignancy to overt hematologic malignancy in patients with RUNX1-FPD. The RUNX1 Research Program and ALSF host an annual scientific meeting that brings together grant recipients and other scientists. Grant recipients are expected to present their progress as part of the annual review. A RUNX1 Early Career Investigator Grant is $180,000 over 3 years (maximum $60,000 per year may be requested)

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.